1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Burgess, R.W.; Skarnes, W.C.; Sanes, J.R. Agrin isoforms with distinct amino termini: Differential expression, localization, and
function. J. Cell Biol. 2000, 151, 41–52. [CrossRef] [PubMed]
Guarino, S.R.; Canciani, A.; Forneris, F. Dissecting the Extracellular Complexity of Neuromuscular Junction Organizers. Front.
Mol. Biosci. 2020, 6, 156. [CrossRef] [PubMed]
Reist, N.E.; Werle, M.J.; McMahan, U.J. Agrin released by motor neurons induces the aggregation of acetylcholine receptors at
neuromuscular junctions. Neuron 1992, 8, 865–868. [CrossRef] [PubMed]
Ferns, M.J.; Campanelli, J.T.; Hoch, W.; Scheller, R.H.; Hall, Z. The ability of agrin to cluster AChRs depends on alternative
splicing and on cell surface proteoglycans. Neuron 1993, 11, 491–502. [CrossRef] [PubMed]
Ohno, K.; Ohkawara, B.; Shen, X.-M.; Selcen, D.; Engel, A.G. Clinical and Pathologic Features of Congenital Myasthenic
Syndromes Caused by 35 Genes−A Comprehensive Review. Int. J. Mol. Sci. 2023, 24, 3730. [CrossRef]
Ohkawara, B.; Shen, X.-M.; Selcen, D.; Nazim, M.; Bril, V.; Tarnopolsky, A.M.; Brady, L.; Fukami, S.; Amato, A.A.; Yis, U.; et al.
Congenital myasthenic syndrome−associated agrin variants affect clustering of acetylcholine receptors in a domain−specific
manner. J. Clin. Investig. 2020, 5, e132023. [CrossRef]
Zhang, Z.; Pinto, A.; Wan, L.; Wang, W.; Berg, M.; Oliva, I.; Singh, L.; Dengler, C.; Wei, Z.; Dreyfuss, G. Dysregulation of
synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 2013, 110,
19348–19353. [CrossRef]
Boido, M.; Amicis, E.; Valsecchi, V.; Trevisan, M.; Ala, U.; Ruegg, M.A.; Hettwer, S.; Vercelli, A. Increasing agrin function
antagonizes muscle atrophy and motor impairment in spinal muscular atrophy. Front. Cell. Neurosci. 2018, 12, 17. [CrossRef]
Kim, J.-K.; Caine, C.; Awano, T.; Herbst, R.; Monani, U.R. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the
severity of the spinal muscular atrophy disease phenotype in model mice. Hum. Mol. Genet. 2017, 26, 2377–2385. [CrossRef]
Hoch, W.; Ferns, M.; Campanelli, J.T.; Hall, Z.W.; Scheller, R.H. Developmental regulation of highly active alternatively spliced
forms of agrin. Neuron 1993, 11, 479–490. [CrossRef]
Ohno, K.; Rahman, M.A.; Nazim, M.; Nasrin, F.; Lin, Y.; Takeda, J.I.; Masuda, A. Splicing regulation and dysregulation of
cholinergic genes expressed at the neuromuscular junction. J. Neurochem. 2017, 142, 64–72. [CrossRef] [PubMed]
Ruggiu, M.; Herbst, R.; Kim, N.; Jevesk, M.; Fak, J.J.; Mann, M.; Fischbach, G.; Burden, S.; Darnell, R. Rescuing Z+ agrin splicing
in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc. Natl. Acad. Sci.
USA 2009, 106, 3513–3518. [CrossRef] [PubMed]
Burgess, R.W.; Nguyen, Q.T.; Son, Y.-J.; Lichtman, J.W.; Sanes, J.R. Alternatively Spliced Isoforms of Nerve− and Muscle−Derived
Agrin. Neuron 1999, 23, 33–44. [CrossRef] [PubMed]
Ma, E.; Morgan, R.; Godfrey, E. Distribution of agrin mRNAs in the chick embryo nervous system. J. Neurosci. 1994, 14, 2943–2952.
[CrossRef]
Nikolaou, N.; Gordon, P.M.; Hamid, F.; Taylor, R.; Lloyd, J.-J.; Makeyev, E.V.; Houart, C. Cytoplasmic pool of U1 spliceosome
protein SNRNP70 shapes the axonal transcriptome and regulates motor connectivity. Curr. Biol. 2022, 32, 5099–5115. [CrossRef]
Gesemann, M.; Denzer, A.J.; Ruegg, M.A. Acetylcholine receptor−aggregating activity of agrin isoforms and mapping of the
active site. J. Cell Biol. 1995, 128, 625–636. [CrossRef]
Wei, N.; Lin, C.Q.; Modafferi, E.F.; Gomes, W.A.; Black, D.L. A unique intronic splicing enhancer controls the inclusion of the
agrin Y exon. RNA 1997, 3, 1275–1288.
Saulière, J.; Sureau, A.; Expert−Bezançon, A.; Marie, J. The polypyrimidine tract binding protein (PTB) represses splicing of exon
6B from the beta−tropomyosin pre−mRNA by directly interfering with the binding of the U2AF65 subunit. J. Cell Biol. 2006, 26,
8755–8769. [CrossRef]
Int. J. Mol. Sci. 2023, 24, 7420
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
16 of 17
Lamichhane, R.; Daubner, G.M.; Thomas−Crusells, J.; Auweter, S.D.; Manatschal, C.; Austin, K.S.; Valniuk, O.; Allain, F.H.-T.;
Rueda, D. RNA looping by PTB: Evidence using FRET and NMR spectroscopy for a role in splicing repression. Proc. Natl. Acad.
Sci. USA 2010, 107, 4105–4110. [CrossRef]
Wagner, E.J.; Garcia−Blanco, M.A. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 2001, 21,
3281–3288. [CrossRef]
Ashiya, M.; Grabowski, P.J. A neuron−specific splicing switch mediated by an array of pre−mRNA repressor sites: Evidence of
a regulatory role for the polypyrimidine tract binding protein and a brain−specific PTB counterpart. RNA 1997, 3, 996–1015.
[PubMed]
Boutz, P.L.; Stoilov, P.; Li, Q.; Lin, C.; Chawla, G.; Ostrow, K.; Shiue, L.; Ares, M.; Black, D.L. A post−transcriptional regulatory
switch in polypyrimidine tract−binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 2007, 21,
1636–1652. [CrossRef] [PubMed]
Coutinho−Mansfield, G.C.; Xue, Y.; Zhang, Y.; Fu, X.-D. PTB/nPTB switch: A post−transcriptional mechanism for programming
neuronal differentiation. Genes Dev. 2007, 21, 1573–1577. [CrossRef] [PubMed]
Lonsdale, J.; Thomas, J.; Salvatore, M.; Phillips, R.; Lo, E.; Shad, S. The Genotype−Tissue Expression (GTEx) project. Nat. Genet.
2013, 45, 580–585. [CrossRef] [PubMed]
Mallet, J.; Houhou, L.; Pajak, F.; Oda, Y.; Cervini, R.; Bejanin, S.; Berrard, S. The cholinergic locus: ChAT and VAChT genes.
J. Physiol. 1998, 92, 145–147. [CrossRef] [PubMed]
Takase, K.; Mitsushima, D.; Funabashi, T.; Kimura, F. Sex difference in the 24−h acetylcholine release profile in the premotor/supplementary motor area of behaving rats. Brain Res. 2007, 1154, 105–115. [CrossRef] [PubMed]
Amir−Ahmady, B.; Boutz, P.L.; Markovtsov, V.; Phillips, M.L.; Black, D.L. Exon repression by polypyrimidine tract binding
protein. RNA 2005, 11, 699–716. [CrossRef]
Luo, Y.; Hitz, B.C.; Gabdank, I.; A Hilton, J.; Kagda, M.S.; Lam, B.; Myers, Z.; Sud, P.; Jou, J.; Lin, K.; et al. New developments on
the Encyclopedia of DNA Elements (ENCODE) data portal. Nucleic Acids Res. 2019, 48, D882–D889. [CrossRef]
Robinson, J.T.; Thorvaldsdóttir, H.; Winckler, W.; Guttman, M.; Lander, E.S.; Getz, G.; Mesirov, J.P. Integrative genomics viewer.
Nat. Biotechnol. 2011, 29, 24–26. [CrossRef]
Van Nostrand, E.L.; Freese, P.; Pratt, G.A.; Wang, X.; Wei, X.; Xiao, R.; Blue, S.M.; Chen, J.-Y.; Cody, N.A.L.; Dominguez, D.; et al.
A large−scale binding and functional map of human RNA−binding proteins. Nature 2020, 583, 711–719. [CrossRef]
Piva, F.; Giulietti, M.; Burini, A.B.; Principato, G. SpliceAid 2: A database of human splicing factors expression data and RNA
target motifs. Hum. Mutat. 2011, 33, 81–85. [CrossRef] [PubMed]
Spellman, R.; Llorian, M.; Smith, C.W.J. Crossregulation and Functional Redundancy between the Splicing Regulator PTB and Its
Paralogs nPTB and ROD1. Mol. Cell 2007, 27, 420–434. [CrossRef] [PubMed]
Oberstrass, F.C.; Auweter, S.D.; Erat, M.; Hargous, Y.; Henning, A.; Wenter, P.; Reymond, L.; Amir−Ahmady, B.; Pitsch, S.; Black,
D.L.; et al. Structure of PTB bound to RNA: Specific binding and implications for splicing regulation. Science 2005, 309, 2054–2057.
[CrossRef] [PubMed]
Liu, H.; Zhang, W.; Reed, R.B.; Liu, W.; Grabowski, P.J. Mutations in RRM4 uncouple the splicing repression and RNA−binding
activities of polypyrimidine tract binding protein. RNA 2002, 8, 137–149. [CrossRef]
Zhang, H.; Sathyamurthy, A.; Liu, F.; Li, L.; Zhang, L.; Dong, Z.; Cui, W.; Sun, X.; Zhao, K.; Wang, H.; et al. Agrin−Lrp4−Ror2
signaling regulates adult hippocampal neurogenesis in mice. Elife 2019, 8, e45303. [CrossRef]
Kim, M.J.; Liu, I.; Song, Y.; Lee, J.; Halfter, W.; Balice−Gordon, R.J.; Linney, E.; Cole, G.J. Agrin is required for posterior
development and motor axon outgrowth and branching in embryonic zebrafish. Glycobiology 2006, 17, 231–247. [CrossRef]
Irimia, M.; Weatheritt, R.J.; Ellis, J.D.; Parikshak, N.N.; Gonatopoulos−Pournatzis, T.; Babor, M.; Quesnel−Vallières, M.; Tapial, J.;
Raj, B.; O’hanlon, D.; et al. A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic Brains. Cell 2014,
159, 1511–1523. [CrossRef] [PubMed]
Porter, R.S.; Jaamour, F.; Iwase, S. Neuron−specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders. Mol. Cell. Neurosci. 2018, 87, 35–45. [CrossRef]
Li, Y.I.; Sanchez−Pulido, L.; Haerty, W.; Ponting, C.P. RBFOX and PTBP1 proteins regulate the alternative splicing of micro−exons
in human brain transcripts. Genome Res. 2014, 25, 1–13. [CrossRef]
Cereda, M.; Pozzoli, U.; Rot, G.; Juvan, P.; Schweitzer, A.; Clark, T.; Ule, J. RNAmotifs: Prediction of multivalent RNA motifs that
control alternative splicing. Genome Biol. 2014, 15, R20. [CrossRef]
Pina, J.M.; Hernandez, L.A.; Keppetipola, N.M. Polypyrimidine tract binding proteins PTBP1 and PTBP2 interact with distinct
proteins under splicing conditions. PLoS ONE 2022, 17, e0263287. [CrossRef] [PubMed]
Hamid, F.M.; Makeyev, E.V. A mechanism underlying position−specific regulation of alternative splicing. Nucleic Acids Res. 2017,
45, 12455–12468. [CrossRef] [PubMed]
Ye, R.; Hu, N.; Cao, C.; Su, R.; Xu, S.; Yang, C.; Zhou, X.; Xue, Y. Capture RIC−seq reveals positional rules of PTBP1−associated
RNA loops in splicing regulation. Mol. Cell 2023, 83, 1–17. [CrossRef] [PubMed]
Beusch, I.; Barraud, P.; Moursy, A.; Cléry, A.; Allain, F.H.-T. Tandem hnRNP A1 RNA recognition motifs act in concert to repress
the splicing of survival motor neuron exon 7. Elife 2017, 6, e25736. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2023, 24, 7420
45.
46.
47.
48.
49.
50.
17 of 17
Spendiff, S.; Howarth, R.; McMacken, G.; Davey, T.; Quinlan, K.; O’Connor, E.; Slater, C.; Hettwer, S.; Mäder, A.; Roos, A.; et al.
Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength
in a Mouse Model of Congenital Myasthenic Syndrome. Front. Mol. Neurosci. 2020, 13, 594220. [CrossRef]
Li, Z.; Li, M.; Wood, K.; Hettwer, S.; Muley, S.; Shi, F.; Liu, Q.; Ladha, S. Engineered agrin attenuates the severity of experimental
autoimmune myasthenia gravis. Muscle Nerve 2017, 57, 814–820. [CrossRef]
Havens, M.A.; Hastings, M.L. Splice−switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res. 2016, 44,
6549–6563. [CrossRef]
Masuda, A.; Shen, X.-M.; Ito, M.; Matsuura, T.; Engel, A.G.; Ohno, K. hnRNP H enhances skipping of a nonfunctional exon P3A
in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum. Mol. Genet. 2008, 17, 4022–4035.
[CrossRef]
Rahman, M.A.; Masuda, A.; Ohe, K.; Ito, M.; Hutchinson, D.O.; Mayeda, A.; Engel, A.G.; Ohno, K. HnRNP L and hnRNP LL
antagonistically modulate PTB−mediated splicing suppression of CHRNA1 pre−Mrna. Sci. Rep. 2013, 3, srep02931. [CrossRef]
Rahman, M.A.; Azuma, Y.; Nasrin, F.; Takeda, J.I.; Nazim, M.; Ahsan, K.B.; Masuda, A.; Engel, A.G.; Ohno, K. SRSF1 and hnRNP
H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome. Sci. Rep. 2015, 5, 13208. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
...